Riskpilot← Back to searchSign inGet full accessLidge Hälsa AB
ABActiveOrg 5569266835Råsundavägen 100General medical practice activities · NACE 8621Est. 20131 employees
Revenue 2024
SEK 3,3M
0% vs 2023
EBITDA margin
30.2%
+623% vs 2023
Equity ratio
24.5%
Financial strength
Net profit 2024
SEK 638K
+1176% vs 2023
| Revenue | SEK 3,3M | +0% |
| EBITDA | SEK 991K | +623% |
| Net profit | SEK 638K | +1176% |
| Total assets | SEK 5,4M | +4% |
| Equity | SEK 1,3M | +27% |
| Employees | 1 | — |
Legal name
Lidge Hälsa AB
Org number
5569266835
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 mars 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultarbete inom sjukvård, skönhetsvård och friskvårdkosmetika, behandlingar, medicinsk laser, estetisk kirurgi, estetisk laser, hårtransplantationer, skönhetsvårdinjektioner och fillers, behandling med lasermaskiner och andra hudvårdsmaskiner, traditionell hudvård, samt försäljning av hud och skönhetsvård produkter. Bolaget skall också driva uthyrning och försäljning av fastigheter, samt äga och förvalta värdepapper, tolk- och informations- samt översättningstjänster ävensom idka därmed förenlig verksamhet.
Address
Råsundavägen 100
Email
seham@almtax.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 1 680 | 2 581 | 2 821 | 3 747 | 4 835 | 4 262 | 3 265 | 3 278 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 654 | 486 | 393 | 523 | 547 | 1 514 | 1 678 | 1 633 | 137 | 991 |
| Depreciation & amort. | −80 | −80 | −80 | −60 | −60 | −100 | −100 | −100 | −40 | −125 |
| EBIT | 574 | 406 | 313 | 463 | 487 | 1 414 | 1 578 | 1 533 | 97 | 866 |
| Net financials | −4 | — | −8 | −606 | — | −6 | −39 | −22 | −3 | −56 |
| Profit before tax | 570 | 406 | 304 | −142 | 487 | 1 056 | 1 154 | 1 136 | 68 | 812 |
| Tax | −126 | −91 | −70 | −0 | −77 | −226 | −238 | −236 | −18 | −174 |
| Net profit | 444 | 315 | 234 | −142 | 410 | 830 | 916 | 900 | 50 | 638 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 821 | 957 | 1 796 | 981 | 1 074 | 5 020 | 4 848 | 4 748 | 5 134 | 5 359 |
| Equity | 683 | 833 | 897 | 455 | 585 | 1 215 | 1 131 | 1 431 | 1 031 | 1 311 |
| Long-term debt | 0 | 0 | 700 | 0 | 0 | 725 | 1 069 | 862 | 810 | 1 557 |
| Short-term debt | 138 | 124 | 199 | 526 | 489 | 2 729 | 1 911 | 1 343 | 2 155 | 1 354 |
| Total debt | 138 | 124 | 899 | 526 | 489 | 3 454 | 2 980 | 2 205 | 2 965 | 2 911 |
EBITDA margin
30.2%
This company
15.8%
Market median
+91% vs market
20152024
Equity ratio
24.5%
This company
38.2%
Market median
-36% vs market
20152024
Return on equity
48.7%
This company
18.4%
Market median
+165% vs market
20152024
Net profit margin
19.5%
This company
8.1%
Market median
+141% vs market
20152024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20152024
Debt / equity
3.09×
This company
0.62×
Market median
-398% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JI Chief Auditor | Chief Auditor | 2022 | — | — |
TC Audit | Audit | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lidge Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jose Ignacio Roa Cortes | Chief Auditor | 0 companies |
| Thérese Carina Ek | Audit | 0 companies |
| Nora Yaneth Dominguez Lidge | Board of Directors | 0 companies |
| Fakhri Lidge | Deputy Board Member | 0 companies |